What is Briacell Therapeutics Corp. Common Shares's Market Cap?

Briacell Therapeutics Corp. Common Shares's Market Cap is $31.2M, based on as-reported figures from SEC (XBRL) filings.

What is Briacell Therapeutics Corp. Common Shares's Enterprise Value?

Briacell Therapeutics Corp. Common Shares's Enterprise Value is $8.4M, based on as-reported figures from SEC (XBRL) filings.

What is Briacell Therapeutics Corp. Common Shares's EV / EBITDA?

Briacell Therapeutics Corp. Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Briacell Therapeutics Corp. Common Shares's Net Income (TTM)?

Briacell Therapeutics Corp. Common Shares's Net Income (TTM) is -$30.7M, based on as-reported figures from SEC (XBRL) filings.

What is Briacell Therapeutics Corp. Common Shares's EBITDA?

Briacell Therapeutics Corp. Common Shares's EBITDA is -$31.9M, based on as-reported figures from SEC (XBRL) filings.

What is Briacell Therapeutics Corp. Common Shares's Diluted EPS (TTM)?

Briacell Therapeutics Corp. Common Shares's Diluted EPS (TTM) is -3.53, based on as-reported figures from SEC (XBRL) filings.

What is Briacell Therapeutics Corp. Common Shares's Net Debt?

Briacell Therapeutics Corp. Common Shares's Net Debt is -$22.8M, based on as-reported figures from SEC (XBRL) filings.

Briacell Therapeutics Corp. Common Shares (BCTX) Financial Statements

Briacell Therapeutics Corp. Common Shares

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SMHR46

XNAS · usd

3.59▲ 0.01 (0.28%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close3.58

Day's Range3.42 – 3.62

52-Week Range2.60 – 14.68

Volume145.2K

Avg Volume441.4K

Share Statistics

Shares Outstanding

Employees4

ExchangeXNAS

Listed2023-09-05

Share count as of June 9, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Briacell Therapeutics Corp. Common Shares (BCTX)

What is Briacell Therapeutics Corp. Common Shares's Market Cap?: Briacell Therapeutics Corp. Common Shares's Market Cap is $31.2M, based on as-reported figures from SEC (XBRL) filings.
What is Briacell Therapeutics Corp. Common Shares's Enterprise Value?: Briacell Therapeutics Corp. Common Shares's Enterprise Value is $8.4M, based on as-reported figures from SEC (XBRL) filings.
What is Briacell Therapeutics Corp. Common Shares's EV / EBITDA?: Briacell Therapeutics Corp. Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Briacell Therapeutics Corp. Common Shares's Net Income (TTM)?: Briacell Therapeutics Corp. Common Shares's Net Income (TTM) is -$30.7M, based on as-reported figures from SEC (XBRL) filings.
What is Briacell Therapeutics Corp. Common Shares's EBITDA?: Briacell Therapeutics Corp. Common Shares's EBITDA is -$31.9M, based on as-reported figures from SEC (XBRL) filings.
What is Briacell Therapeutics Corp. Common Shares's Diluted EPS (TTM)?: Briacell Therapeutics Corp. Common Shares's Diluted EPS (TTM) is -3.53, based on as-reported figures from SEC (XBRL) filings.
What is Briacell Therapeutics Corp. Common Shares's Net Debt?: Briacell Therapeutics Corp. Common Shares's Net Debt is -$22.8M, based on as-reported figures from SEC (XBRL) filings.